Word

PEGBERON

Status

Dead

Status Code

602

Status Date

Tuesday, April 4, 2023

Serial Number

90843638

Mark Type

4000

Filing Date

Thursday, July 22, 2021

Abandoned Date

Monday, March 13, 2023

Trademark Owner History

XIAMEN AMOYTOP BIOTECH CO., LTD.

Classifications

5 Medicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; Chemical preparations for testing blood for medical purposes; Dietetic substances adapted for medical use; Biocides; first aid kits; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; Clinical medical reagents; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; Medicinal preparations for the mouth and as sprays

Trademark Events

Apr 4, 2023

Abandonment Notice E-Mailed - Failure To Respond

Apr 4, 2023

Abandonment Notice Mailed - Failure To Respond

Apr 4, 2023

Abandonment - Failure To Respond Or Late Response

Dec 12, 2022

Notification Of Non-Final Action E-Mailed

Dec 12, 2022

Non-Final Action E-Mailed

Dec 12, 2022

Non-Final Action Written

May 26, 2022

Notification Of Non-Final Action E-Mailed

May 26, 2022

Non-Final Action E-Mailed

May 26, 2022

Non-Final Action Written

May 21, 2022

Teas/Email Correspondence Entered

May 20, 2022

Correspondence Received In Law Office

May 20, 2022

Teas Response To Office Action Received

Apr 21, 2022

Notification Of Non-Final Action E-Mailed

Apr 21, 2022

Non-Final Action E-Mailed

Apr 21, 2022

Non-Final Action Written

Apr 15, 2022

Assigned To Examiner

Sep 23, 2021

New Application Office Supplied Data Entered

Jul 26, 2021

New Application Entered